MAFLD: What Is It?

Houston Methodist

D. Victor

Acute Kidney Injury in Cirrhosis (AKI HRS): The Known and Unknown

MUSC Health

M. Curry

Contrast Nephropathy

ARCH Advanced Revascularization Symposium

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Promoting Renal Resilience in Sepsis: Emerging Paradigms and Clinica…

Houston Methodist

M. Ostermann

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Important Safety Information - Off-Target Effects of New Therapies f…

Ronald Goldenberg

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liv…

UCSF School of Medicine

M. A. Ohliger

Kidney Week 2023 Insights: Point-of-care Ultrasound (POCUS) Assisted…

Kidney Week 2023 Insights

A. Koratala

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

Alcohol Associated Liver Disease: Current & Future Therapies

Houston Methodist

J. Pablo Arab

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

Updates in Nephrology

University of Colorado Department of Medicine

A. Jovanovich

Update on Hepatology Literature

UCLA Health

J. Benhammou, C. Wong